ASML Stock Slides Over 4% as AI Development Concerns Hit Chip Sector

Shares in ASML Holding N.V. (ASML) dropped significantly in recent trading, caught in a broad market retreat that hit semiconductor-related equities. The sell-off was fueled by investor concerns over the future pace of artificial intelligence development.

AI Caution Triggers Sell-Off

The primary catalyst for the downturn was commentary from the leaders of prominent AI labs OpenAI and Anthropic, who called for a temporary slowdown in the creation of advanced AI models. According to a report from Investing.com, these statements rattled confidence in the near-term demand outlook for the sophisticated equipment used to manufacture high-end chips.

As a bellwether for the semiconductor industry, ASML was disproportionately affected by the negative sentiment. The stock slid 4.3% to €1,415.60, leading declines in the European chip sector.

Broader Market Headwinds

Adding to the pressure was a lingering price target reduction from Morgan Stanley last week. While the bank maintained an Overweight rating, it trimmed its target on ASML to €1,700 from €1,930, signaling a more cautious view on the stock's near-term potential.

Ad

The decline occurred amid a wider risk-off tone in global technology markets, with the Nasdaq Composite in the U.S. also trading lower. With no fresh company-specific news to offset the macro narrative, and with its next earnings report not due until October 14, ASML's stock was left vulnerable to the broader sector trend.

Long-Term Outlook

Despite the single-day pullback, the source report noted that ASML's fundamental business case remains strong. The company has previously raised its full-year 2026 revenue outlook and maintains strong order visibility for its critical extreme ultraviolet (EUV) lithography systems.

The stock continues to trade well above its 52-week low of €695.20, suggesting the recent decline is more reflective of short-term market sentiment than a structural deterioration in the company's long-term prospects.